Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria (Q33534711)

27 July 2017

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria (English)

1 reference

27 July 2017

gram-positive bacteria

0 references

Gram-negative bacteria

0 references

0 references

5

Matthew E Falagas

1 reference

27 July 2017

2

Petros I Rafailidis

1 reference

27 July 2017

4

Ioannis D Gkegkes

1 reference

27 July 2017

Antonia C Kastoris

1

1 reference

27 July 2017

Evridiki K Vouloumanou

series ordinal

3

1 reference

27 July 2017

language of work or name

1 reference

26 February 2010

1 reference

European Journal of Clinical Pharmacology

27 July 2017

1 reference

27 July 2017

66

1 reference

27 July 2017

4

1 reference

27 July 2017

359-368

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-010-0794-5

27 July 2017

0 references

cites work

Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0794-5

In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii

21 January 2018

1 reference

12 December 2020

Treatment of neurosurgical bacterial meningitis using the combination of ceftriaxone-fosfomycin

1 reference

12 December 2020

In-vitro activity of the combination of ceftriaxone and fosfomycin against staphylococci

1 reference

12 December 2020

Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.

1 reference

12 December 2020

Synergism between ciprofloxacin and fosfomycin in vitro

1 reference

12 December 2020

Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.

1 reference

12 December 2020

Addressing the challenge of extended-spectrum beta-lactamases.

1 reference

12 December 2020

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

12 December 2020

In vitro activity of fosfomycin against 'problem' gram-positive cocci

1 reference

12 December 2020

In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin

1 reference

12 December 2020

Antibiotherapy of Serratia marcescens septicemia in children

1 reference

12 December 2020

[Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus]

1 reference

12 December 2020

Interaction of fosfomycin with other antimicrobial agents: in vitro and in vivo studies

1 reference

12 December 2020

Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa

1 reference

12 December 2020

In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.

1 reference

12 December 2020

The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats

1 reference

12 December 2020

Activities of beta-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections

1 reference

12 December 2020

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

1 reference

12 December 2020

Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?

1 reference

12 December 2020

Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics

1 reference

12 December 2020

In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.

1 reference

12 December 2020

Effect of topical fosfomycin on polymyxin B ototoxicity

1 reference

12 December 2020

[In vitro study of a ceftriaxone-fosfomycin combination on 55 strains of methicillin-sensitive and heterogeneous methicillin-resistant Staphylococcus aureus]

1 reference

12 December 2020

The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci

1 reference

12 December 2020

Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci

1 reference

12 December 2020

In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole

1 reference

12 December 2020

Potential of old-generation antibiotics to address current need for new antibiotics

1 reference

12 December 2020

Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26

1 reference

12 December 2020

In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa

1 reference

12 December 2020

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms

1 reference

12 December 2020

Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm

1 reference

12 December 2020

In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci

1 reference

12 December 2020

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

12 December 2020

[Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study]

1 reference

12 December 2020

Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

1 reference

12 December 2020

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

1 reference

12 December 2020

Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm

1 reference

12 December 2020

In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus

1 reference

12 December 2020

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

1 reference

12 December 2020

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections

1 reference

12 December 2020

Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin

1 reference

12 December 2020

[Treatment of post-traumatic and post-neurosurgical bacterial meningitis with ceftriaxone alone or in combination with fosfomycin]

1 reference

12 December 2020

Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci

1 reference

12 December 2020

Fosfomycin: use beyond urinary tract and gastrointestinal infections

1 reference

12 December 2020

Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases

1 reference

12 December 2020

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

12 December 2020

In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus

1 reference

12 December 2020

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

1 reference

12 December 2020

Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain

1 reference

12 December 2020

Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats

1 reference

12 December 2020

10.1007/S00228-010-0794-5

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference